Towa Pharmaceutical Co Ltd 2023 SR
The report highlights Towa Group's commitment to the stable supply and quality of generic drugs while advancing its sustainability initiatives. The company announced its support for TCFD recommendations and conducted scenario analysis to assess climate-related risks and opportunities. Key environmental targets include a 30% reduction in Scope 1 and 2 emissions by FY2030 and achieving carbon neutrality by FY2050. Socially, the company focuses on human resource development, achieving a 12.8% ratio of women in management positions. Governance is strengthened through an Audit and Supervisory Committee and a Risk Management Committee overseeing climate issues.
Company: Towa Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2023
Type: SR
Pages: 9
Towa Pharmaceutical Co Ltd
Sustainability Report
The report highlights Towa Group's commitment to the stable supply and quality of generic drugs while advancing its sustainability initiatives. The company announced its support for TCFD recommendations and conducted scenario analysis to assess climate-related risks and opportunities. Key environmental targets include a 30% reduction in Scope 1 and 2 emissions by FY2030 and achieving carbon neutrality by FY2050. Socially, the company focuses on human resource development, achieving a 12.8% ratio of women in management positions. Governance is strengthened through an Audit and Supervisory Committee and a Risk Management Committee overseeing climate issues.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2022
Published
Nov 30, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Net Zero Target